查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1544095

全球鞘内帮浦市场

Intrathecal Pumps
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球鞘内帮浦市场预计将达到3.699亿美元

2023 年全球鞘内帮浦市场预计为 2.625 亿美元，预计在 2023-2030 年分析期间将以 5.0% 的复合年增长率成长，到 2030 年将达到 3.699 亿美元。氢可酮是本报告分析的细分市场之一，预计复合年增长率为 4.9%，到分析期结束时将达到 1.159 亿美元。齐考诺肽细分市场在分析期间的复合年增长率预计为 5.6%。

美国市场预估为7,140万美元，中国预期复合年增长率为4.8%

预计 2023 年美国鞘内帮浦市场规模将达 7,140 万美元。中国作为全球第二大经济体，预计2030年市场规模将达5,880万美元，2023-2030年分析期间复合年增长率为4.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.6% 和 4.3%。在欧洲，德国预计复合年增长率为 5.0%。

全球鞘内帮浦市场－主要趋势与驱动因素总结

什么是鞘内帮浦？

鞘内帮浦是将药物直接输送到脊髓液中的医疗设备，用于缓解慢性疾病患者的疼痛和痉挛。这些帮浦对于治疗对口服药物或其他治疗方法效果不佳的严重、顽固性疼痛和痉挛至关重要。与传统的疼痛管理方法相比，透过直接向中枢神经系统给药，所需剂量更低，全身性副作用也减少。它对于癌症疼痛、背部手术失败症候群和多发性硬化症患者尤其有益。随着慢性疼痛和神经系统疾病的盛行率持续上升，鞘内帮浦对于为这些患者提供有效和持续的缓解变得越来越重要。

技术进步如何形塑鞘内帮浦市场？

技术进步正在显着塑造鞘内泵市场，特别是透过泵浦设计、药物传输准确性和病患监测方面的创新。现代鞘内帮浦更加紧凑、可程式设计，并且可以根据患者的个人需求进行精确的剂量调整。电池技术的进步延长了这些设备的使用寿命，并减少了频繁更换和充电的需要。此外，无线通讯和远端监控功能的整合使医疗保健提供者能够即时调整帮浦设定并监控患者的进展，从而提高疼痛和痉挛管理的整体有效性和安全性。这些创新促进了鞘内泵成为慢性病长期管理的首选方案，为患者提供了更高的生活品质。

为什么疼痛管理和神经病学对鞘内泵的需求不断增加？

在疼痛管理和神经病学领域，由于慢性疼痛发病率的增加、人口老化以及传统疼痛缓解方法的局限性，对鞘内泵的需求不断增加。随着越来越多的患者寻求有效、长期的解决方案来控制严重疼痛和痉挛，鞘内帮浦已成为一种重要的选择，特别是对于那些无法透过常规治疗缓解的患者。世界人口老化也促进了需求，因为老年人更有可能患有需要强化疼痛管理的慢性疾病。此外，鸦片类药物危机凸显了对替代性疼痛管理策略的需求，导致人们越来越重视鞘内给药作为更安全、更有效的选择。随着医疗保健提供者和患者对鞘内帮浦益处的认识不断增强，预计该市场将会扩大。

推动鞘内帮浦市场成长的因素有哪些？

鞘内泵市场的成长是由与技术进步、慢性疼痛和神经系统疾病盛行率增加以及对替代疼痛管理解决方案的需求不断增长相关的几个因素所推动的。主要驱动力之一是泵浦技术的进步，提高了这些设备的准确性、安全性和易用性。癌症和多发性硬化症等导致严重疼痛和痉挛的慢性疾病的盛行率不断上升，也推动了对鞘内帮浦的需求。人们越来越认识到与全身性止痛药物（尤其是阿片类药物）相关的风险，正在推动鞘内泵作为更安全、更有效的替代方案的采用。此外，增加对医疗基础设施的投资和扩大疼痛管理诊所也透过为更多患者提供先进的治疗来促进市场成长。随着这些趋势的不断发展，由于对创新、有效和以患者为中心的疼痛管理解决方案的需求，鞘内帮浦市场预计将持续成长。

调查企业范例（共42例）

  • Advance Neuromodulation System
  • Advanced Bionics
  • Arrow International
  • Baxter
  • Boston Scientific
  • Codman & Shurtleff
  • DJO Global
  • Dynacast
  • Flowonix Medical
  • Inteprod
  • Johnson and Johnson Services, Inc.
  • Medallion Therapeutics
  • Medasys
  • Medtronic plc
  • Perlong Medical Equipment
  • Qinhuangdao Sanwin Trading
  • Smiths Medical
  • St. Jude Medical
  • Stryker
  • Teleflex
  • Tricumed

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12830

Global Intrathecal Pumps Market to Reach US$369.9 Million by 2030

The global market for Intrathecal Pumps estimated at US$262.5 Million in the year 2023, is expected to reach US$369.9 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the analysis period. Growth in the Ziconotide segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$71.4 Million While China is Forecast to Grow at 4.8% CAGR

The Intrathecal Pumps market in the U.S. is estimated at US$71.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$58.8 Million by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Intrathecal Pumps Market - Key Trends & Drivers Summarized

What Are Intrathecal Pumps and Why Are They Critical for Chronic Pain and Spasticity Management?

Intrathecal pumps are medical devices used to deliver medications directly into the spinal fluid, offering targeted pain relief and management of spasticity in patients with chronic conditions. These pumps are critical in managing severe, intractable pain and spasticity that do not respond well to oral medications or other treatments. By delivering medication directly to the central nervous system, intrathecal pumps allow for lower dosages and reduced systemic side effects compared to traditional pain management methods. They are particularly beneficial for patients with conditions such as cancer pain, failed back surgery syndrome, and multiple sclerosis. As the prevalence of chronic pain and neurological disorders continues to rise, intrathecal pumps are becoming increasingly vital in providing effective and sustained relief for these patients.

How Are Technological Advancements Shaping the Intrathecal Pumps Market?

Technological advancements are significantly shaping the intrathecal pumps market, particularly through innovations in pump design, drug delivery precision, and patient monitoring. Modern intrathecal pumps are now more compact, programmable, and capable of delivering precise doses tailored to the individual needs of patients. Advances in battery technology have extended the lifespan of these devices, reducing the need for frequent replacements or recharging. Additionally, the integration of wireless communication and remote monitoring capabilities is allowing healthcare providers to adjust pump settings and monitor patient progress in real-time, enhancing the overall effectiveness and safety of pain and spasticity management. These innovations are driving the adoption of intrathecal pumps as a preferred option for long-term management of chronic conditions, offering patients a higher quality of life.

Why Is There an Increasing Demand for Intrathecal Pumps in Pain Management and Neurology?

The demand for intrathecal pumps is increasing in pain management and neurology due to the growing incidence of chronic pain, the aging population, and the limitations of traditional pain relief methods. As more patients seek effective, long-term solutions for managing severe pain and spasticity, intrathecal pumps are emerging as a critical option, particularly for those who have not found relief through conventional treatments. The aging global population is also contributing to the demand, as older adults are more likely to suffer from chronic conditions that require intensive pain management. Furthermore, the opioid crisis has highlighted the need for alternative pain management strategies, leading to a greater emphasis on intrathecal drug delivery as a safer and more effective option. As awareness of the benefits of intrathecal pumps continues to grow among healthcare providers and patients, the market is expected to expand.

What Factors Are Driving the Growth in the Intrathecal Pumps Market?

The growth in the intrathecal pumps market is driven by several factors related to technological advancements, the increasing prevalence of chronic pain and neurological disorders, and the growing demand for alternative pain management solutions. One of the primary drivers is the advancement in pump technology, which has improved the precision, safety, and ease of use of these devices. The rising incidence of chronic conditions that cause severe pain and spasticity, such as cancer and multiple sclerosis, is also fueling demand for intrathecal pumps, as these conditions often require long-term, targeted treatment. The growing awareness of the risks associated with systemic pain medications, particularly opioids, is encouraging the adoption of intrathecal pumps as a safer and more effective alternative. Additionally, the increasing investment in healthcare infrastructure and the expansion of pain management clinics are contributing to market growth, as more patients gain access to advanced treatments. As these trends continue to evolve, the intrathecal pumps market is expected to experience sustained growth, driven by the need for innovative, effective, and patient-centric pain management solutions.

Select Competitors (Total 42 Featured) -

  • Advance Neuromodulation System
  • Advanced Bionics
  • Arrow International
  • Baxter
  • Boston Scientific
  • Codman & Shurtleff
  • DJO Global
  • Dynacast
  • Flowonix Medical
  • Inteprod
  • Johnson and Johnson Services, Inc.
  • Medallion Therapeutics
  • Medasys
  • Medtronic plc
  • Perlong Medical Equipment
  • Qinhuangdao Sanwin Trading
  • Smiths Medical
  • St. Jude Medical
  • Stryker
  • Teleflex
  • Tricumed

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intrathecal Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Pain Management Solutions Spurs Adoption of Intrathecal Pumps
    • Advancements in Pump Technology Propel Innovation in Intrathecal Drug Delivery
    • Shift Towards Minimally Invasive Pain Management Expands Market Opportunities
    • Increasing Use of Intrathecal Pumps in Treating Chronic Pain and Spasticity
    • Role of Intrathecal Pumps in Reducing Opioid Consumption
    • Growing Importance of Personalized Pain Management Solutions
    • Advancements in Implantable Devices Propel Market Growth
    • Emerging Markets Present New Opportunities for Intrathecal Pump Manufacturers
    • Push for Cost-Effective and Long-Term Pain Relief Solutions
    • Role of Intrathecal Pumps in Enhancing Quality of Life for Patients with Severe Pain
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intrathecal Pumps Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intrathecal Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intrathecal Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intrathecal Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Morphine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Morphine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Morphine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ziconotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ziconotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Ziconotide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Baclofen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Baclofen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Baclofen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Bupivacaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clonidine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clonidine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Clonidine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Spasticity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Spasticity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Spasticity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • CHINA
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intrathecal Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Intrathecal Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030

IV. COMPETITION